Start with a low, welldocumented dose and maintain consistent use for at least eight weeks before judging
is a participant in the Living Kidney Donor Safety Study sponsored by CIHR, a volunteer board member of the American Hypertension Specialists Certification Program, co-chair of C-CHANGE, Physician Organization Chair for CHEP+, and reports honoraria and speaker fees from AstraZeneca, Bayer, Boehringer Ingelheim, CHEP+, Eisai, GSK, Janssen, KMH, Novo Nordisk, and Otsuka
Be prepared for a pelvic exam and possibly an ultrasound during the visit
After pregnancy, and once breastfeeding has ended, GLP-1 treatment can be considered again following an individual medical review
From the moment you enter, you are treated with the individualized care that has made VIVA a Plano staple for over a decade
This selective mechanism of action makes it more precise and safe in regulating growth hormone levels